A translational pediatric leukemia research grant honoring John Voight, focused on accelerating new treatments for children with leukemia—particularly Acute Myelocytic Leukemia (AML). Structured as a two-tier award totaling up to $300,000 over three years.
Eligibility Criteria:
-
Research must be original, novel, and focused on pediatric leukemia, with emphasis on AML.
-
Applicant must hold an MD, PhD, MD/PhD (or equivalent); postdoctoral researchers are eligible.
-
Institution must be U.S.-based and nonprofit or academic.
Funding Details:
-
Tier 1: $100,000 for 1 year (translational pediatric leukemia research).
-
Tier 2: $200,000 for 2 additional years (awarded to successful Tier 1 recipients).
Deadline:
-
Letter of Intent: July 3, 2026
-
Full Proposal (invited only): October 16, 2026
Where to go for further information: